Kerty E, Eidal K
Department of Neurology, Rikshospitalet, University Hospital, Oslo, Norway.
Eur J Ophthalmol. 2006 Mar-Apr;16(2):204-8. doi: 10.1177/112067210601600202.
Botulinum toxin injection is the treatment of choice in cases of benign essential blepharospasm. However, about 10% of the patients do not get sufficient effect from this treatment, and many of them have concomitant apraxia of lid opening.
Over a 3-year period we treated 12 patients. Three had pure apraxia of lid opening and in the other nine it was associated with blepharospasm. All patients were initially treated with botulinum toxin injections with poor results. They underwent surgical treatment like blepharoplasty, limited myectomy, aponeurosis repair, and/or frontalis suspension. Some of them needed post operative botulinum toxin injections in the pretarsal part of orbicularis oculi muscles.
This combined therapy gave good functional and aesthetic results.
The specific causes of blepharospasm and apraxia of lid opening are unknown, but these two conditions coexist in some patients and can be difficult to treat. It is important to make a correct diagnosis, and a combined surgical and botulinum toxin treatment can be very effective.
肉毒杆菌毒素注射是治疗良性特发性眼睑痉挛的首选方法。然而,约10%的患者对此治疗效果不佳,其中许多人伴有睁眼失用症。
在3年期间,我们治疗了12例患者。3例为单纯睁眼失用症,另外9例与眼睑痉挛相关。所有患者最初均接受肉毒杆菌毒素注射,但效果不佳。他们接受了诸如睑成形术、局限性肌切除术、腱膜修复和/或额肌悬吊术等手术治疗。其中一些患者术后需要在眼轮匝肌睑板前部注射肉毒杆菌毒素。
这种联合治疗取得了良好的功能和美学效果。
眼睑痉挛和睁眼失用症的具体病因尚不清楚,但这两种情况在一些患者中并存且可能难以治疗。做出正确诊断很重要,手术和肉毒杆菌毒素联合治疗可能非常有效。